Læknablaðið - 15.07.2001, Blaðsíða 36

FRÆÐIGREINAR / BANDVEFSSTOFNFRUMUR
(CD105). Biochem Biophys Res Commun 1999; 265:134-9.
30. Blair A, Thomas DB. Preferential adhesion of fetal liver
derived primitive haemopoietic progenitor cells to bone
marrow stroma. Br J Haematol 1997; 99: 726-31.
31. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson
SL. Phenotypic and functional comparison of cultures of
marrow-derived mesenchymal stem cells (MSCs) and stromal
cells. J Cell Physiol 1998; 176: 57-66.
32. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression
by human marrow-derived mesenchymal progenitor cells in
vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol
1996; 166: 585-92.
33. Cheng L, Qasba P, Vanguri P, Thiede MA. Human
mesenchymal stem cells support megakaryocyte and pro-
platelet formation from CD34(+) hematopoietic progenitor
cells. J Cell Physiol 2000; 184: 58-69.
34. Weissman IL. Translating stem and progenitor cell biology to
the clinic: barriers and opportunities. Science 2000; 287: 1442-
6.
35. Sale GE, Storb R. Bilateral diffuse pulmonary ectopic
ossification after marrow allograft in a dog. Evidence for
allotransplantation of hemopoietic and mesenchymal stem
cells. Exp Hematol 1983; 11: 961-6.
36. Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required
for bone marrow stromal fibroblast colony formation in vitro.
Br J Haematol 1997; 97: 561-70.
37. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov
BP, Pollard MD, et al. Cultured adherent cells from marrow
can serve as long-lasting precursor cells for bone, cartilage,
and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92:
4857-61.
38. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture
expanded canine mesenchymal stem cells possess
osteochondrogenic potential in vivo and in vitro. Cell
Transplant 1997; 6:125-34.
39. Awad HA, Butler DL, Boivin GP, Smith FN, Malaviya P,
Huibregtse B, et al. Autologous mesenchymal stem cell-
mediated repair of tendon. Tissue Eng 1999; 5: 267-77.
40. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E,
Stornaiuolo A, Cossu G, et al. Muscle regeneration by bone
marrow-derived myogenic progenitors. Science 1998; 279:
1528-30.
41. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME.
Evidence for an inverse relationship between the
differentiation of adipocytic and osteogenic cells in rat marrow
stromal cell cultures. J Cell Sci 1992; 102 (Pt 2): 341-51.
42. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells
migrate throughout forebrain and cerebellum, and they
differentiate into astrocytes after injection into neonatal
mouse brains. Proc Natl Acad Sci U S A 1999; 96: 10711-6.
43. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO,
Pittenger MF. Chondrogenic differentiation of cultured
human mesenchymal stem cells from marrow. Tissue Eng
1998; 4: 415-28.
44. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI,
Goldberg VM, et al. The chondrogenic potential of human
bone-marrow-derived mesenchymal progenitor cells. J Bone
Joint Surg Am 1998; 80:1745-57.
45. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP.
Osteogenic differentiation of purified, culture-expanded
human mesenchymal stem cells in vitro. J Cell Biochem 1997;
64:295-312.
46. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-
renewal, and the osteogenic potential of purified human
mesenchymal stem cells during extensive subcultivation and
following cryopreservation. J Cell Biochem 1997; 64: 278-94.
47. Koc ON, Peters C, Aubourg P, Raghavan S, Dyhouse S,
DeGasperi R, et al. Bone marrow-derived mesenchymal stem
cells remain host-derived despite successful hematopoietic
engraftment after allogeneic transplantation in patients with
lysosomal and peroxisomal storage diseases. Exp Hematol
1999; 27:1675-81.
48. Devine S, Bartholom A. Studies of mesenchymal stem cells in
non-human primates: evaluation of toxicity and engraftment
[abstract]. Blood 1999; 94/Suppl 1: 391a.
49. Laver J, Jhanwar SC, O'Reilly RJ, Castro-Malaspina H. Host
origin of the human hematopoietic microenvironment
following allogeneic bone marrow transplantation. Blood
1987; 70:1966-8.
50. Gordon MY. The origin of stromal cells in patients treated by
bone marrow transplantation. Bone Marrow Transplant 1988;
3: 247-51.
51. Santucci MA, Trabetti E, Martinelli G, Buzzi M, Zaccaria A,
Pileri S, et al. Host origin of bone marrow fibroblasts following
allogeneic bone marrow transplantation for chronic myeloid
leukemia. Bone Marrow Transplant 1992; 10:255-9.
52. Pereira RF, O'Hara MD, Laptev AV, Halford KW, Pollard
MD, Class R, et al. Marrow stromal cells as a source of
progenitor cells for nonhematopoietic tissues in transgenic
mice with a phenotype of osteogenesis imperfecta. Proc Natl
Acad Sci USA 1998; 95:1142-7.
53. Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED.
Cotransplantation of stroma results in enhancement of
engraftment and early expression of donor hematopoietic
stem cells in utero. Exp Hematol 1999; 27:1569-75.
54. Minguell JJ, Conget P, Erices A. Biology and clinical
utilization of mesenchymal progenitor cells. Braz J Med Biol
Res 2000; 33: 881-7.
55. Blazsek I, Delmas Marsalet B, Legras S, Marion S, Machover
D, Misset JL. Large scale recovery and characterization of
stromal cell-associated primitive haemopoietic progenitor
cells from filter-retained human bone marrow. Bone Marrow
Transplant 1999; 23: 647-57.
56. Brandt JE, Galy AH, Luens KM, Travis M, Young J, Tong J, et
al. Bone marrow repopulation by human marrow stem cells
after long-term expansion culture on a porcine endothelial cell
line. Exp Hematol 1998; 26: 950-61.
57. Sandmaier B, Storb R, Kniley J. Evidence of allogenic stomal
engraftment in bone marrow using canine mesenchymal stem
cells [abstract]. Blood 1998; 92/Suppl 1:116a .
58. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth
SE, Caplan AI, et al. Rapid hematopoietic recovery after
coinfusion of autologous-blood stem cells and culture-
expanded marrow mesenchymal stem cells in advanced breast
cancer patients receiving high-dose chemotherapy. J Clin
Oncol 2000; 18: 307-16.
59. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon
PL, Neel M, et al. Transplantability and therapeutic effects of
bone marrow-derived mesenchymal cells in children with
osteogenesis imperfecta [see comments]. Nat Med 1999; 5:
309-13.
60. Prockop DJ. Marrow stromal cells as stem cells for continual
renewal of nonhematopoietic tissues and as potential vectors
for gene therapy. J Cell Biochem Suppl 1998; 31: 284-5.
61. Keating A, Berkahn L, Filshie R. A Phase I study of the
transplantation of genetically marked autologous bone
marrow stromal cells. Hum Gene Ther 1998; 9: 591-600.
62. Schwarz EJ, Alexander GM, Prockop DJ, Azizi SA.
Multipotential marrow stromal cells transduced to produce L-
DOPA: engraftment in a rat model of Parkinson disease. Hum
Gene Ther 1999; 10: 2539-49.
63. Brouard N, Chapel A, Neildez-Nguyen TM, Granotier C,
Khazaal I, Peault B, et al. Transplantation of stromal cells
transduced with the human IL3 gene to stimulate
hematopoiesis in human fetal bone grafts in non-obese,
diabetic-severe combined immunodeficiency mice. Leukemia
1998; 12:1128-35.
632 Læknablaðið 2001/87